XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring Charges (Notes)
 9 Months Ended
Sep. 30, 2018
Restructuring Charges [Abstract]  
Restructuring and Related Activities Disclosure [Text Block]
Restructuring Charges

During the nine months ended September 30, 2018 and the year ended December 31, 2017, restructuring charges were incurred as a result of integrating the HIS acquired operations into our business and include severance costs related to involuntary employee terminations and facility exit costs related to the closure of the Dominican Republic manufacturing facility, which was sold in March 2018. All material charges in regard to these restructuring activities have been incurred as of September 30, 2018. The cumulative amount incurred to date in connection with the HIS acquisition is $21.8 million. Restructuring charges are included in the restructuring, strategic transaction and integration line item in our condensed consolidated statement of operations.

During the year ended December 31, 2015, we incurred restructuring charges related to an agreement with Dr. Lopez, a member of our Board of Directors and a former employee in our research and development department, pursuant to which we bought out Dr. Lopez's right to employment under his then-existing employment agreement. The buy-out, including payroll taxes, is paid in equal monthly installments until December 2020.

The following table summarizes the details of changes in our restructuring-related accrual for the period ended September 30, 2018 (in thousands):

 
Accrued Balance December 31, 2017
 
Charges
Incurred
 
Payments
 
Other Adjustments
 
Accrued Balance
September 30,
 2018
Severance pay and benefits
$
915

 
$
2,870

 
$
(3,327
)
 
$
—

 
$
458

Employment agreement buyout
1,114

 
—

 
(287
)
 
2

 
829

Facility closure expenses
—

 
160

 
(160
)
 
—

 
—

 
$
2,029

 
$
3,030

 
$
(3,774
)
 
$
2

 
$
1,287